Supplementary material:medication usage of Participants with in US Adults with Metabolic Syndrome

<p>Supplementary Figure 1 The Kaplan-Meier survival curves of Cholesterol medicine and all-cause mortality in metabolic syndrome participants</p> <p>Supplementary Figure 2 The Kaplan-Meier survival curves of hypertension medicine and all-cause mortality in metabolic syndrome participants</p> <p>Supplementary Table 1 The medication usage of Participants with Metabolic Syndrome Classified by CYSC</p> <p>Supplementary Table 2 Baseline Characteristics of Participants with metabolic syndrome classified by mortality</p>